Given Rises to 5-Month High as Patients Enroll in Pillcam Trial

Given Imaging Ltd. advanced to the highest in more than five months after the maker of a pill-sized camera to diagnose digestive ailments said about 700 patients have enrolled in a PillCam COLON 2 trial.

The shares gained 2.2 percent to 69.21 shekels, the highest intraday level since July 27, at 3:48 p.m. in Tel Aviv.